US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
USOTC
Evofem Biosciences Inc (QB) (EVFM)
Evofem Biosciences Inc (QB) (EVFM) ニュース

EVFM

Evofem Biosciences (QB) (EVFM)

Evofem Biosciences Inc (QB)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:EVFM

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	19 : 50	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/05/15	19 : 45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/03/07	07 : 14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/02/15	04 : 14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/02/01	23 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/02/01	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/01/26	06 : 23	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/01/13	07 : 13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:EVFM	Evofem Biosciences Inc (QB)
2024/01/12	06 : 53	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/12/13	07 : 17	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/12/08	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/10/24	20 : 40	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/10/04	05 : 07	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/09/27	21 : 50	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/09/16	05 : 49	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/09/11	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/30	05 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/29	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/19	05 : 08	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/19	05 : 05	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/15	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/15	06 : 26	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/15	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/15	06 : 24	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/11	06 : 29	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/08/04	06 : 31	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/07/18	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/07/11	06 : 16	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/06/17	06 : 01	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:EVFM	Evofem Biosciences Inc (QB)
2023/06/17	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:EVFM	Evofem Biosciences Inc (QB)

Showing the most relevant articles for your search:USOTC:EVFM

Nexans Paris ACT (PK)

Vontobel Financial Produ...

Live Oak Bancshares

FRCF26 - 01/2026

Nissan Chemical (PK)

BriaCell Therapeutics

Goldman Sachs Bank Usa P...

Eureka U.S. Treasury Obligations

Ishr Sp 500 E H

Spindox Tf 4,5% Ap25 Amo...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約